JAIME CAMPBELL: Open Payments
NPI 1215518683 · GRANITE CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 53 payments from 14 companies in 2025. Trend: 2023 $498 · 2024 $316 · 2025 $1,010
Food & beverage: $933Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $184 |
| Otsuka America Pharmaceutical, Inc. | 10 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $130 |
| Lundbeck LLC | 4 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Neurocrine BioSciences, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $67 |
| Alkermes, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, ABILIFY ASIMTUFII, INGREZZA, COBENFY, ARISTADA.
Industry payments across IL — which companies pay providers there.
